课题基金 / 基金详情

The role of monocytes in the regulation of GVHD after allogeneic stem cell transplantation.

The role of monocytes in the regulation of GVHD after allogeneic stem cell transplantation.
单核细胞在同种异体干细胞移植后 GVHD 调节中的作用。
批准号:
11670976
负责人:
TANAKA Junji
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

TANAKA Junji的其他基金

相似基金

相关文献

中文摘要
翻译
尽管粒细胞集落刺激因子(G-CSF)动员的外周血单核细胞(G-PBMC)移植的T细胞数量至少是标准骨髓移植的10倍,但急性移植物抗宿主病(AGVHD)的发生率和严重程度并不高于异基因骨髓。我们发现,共刺激分子CD28应答复合体在CD4+细胞中的诱导似乎被G-PBMC中CD14+细胞的存在所抑制。最近的研究表明,NK细胞上的抑制性自然杀伤细胞受体(NKRs)通过与MHC-I类分子结合来负向调节NK细胞和T细胞的功能。CD94/NKG2异源二聚体是人类白细胞抗原E非经典分子的受体。我们发现cGVHD患者T细胞表面CD94/NKG2A的表达在常规免疫抑制治疗效果良好的cGVHD患者中明显高于cGVHD治疗效果差的患者。此外,我们还报道了混合淋巴细胞培养(MLC)后G-PBMC中CD8+T细胞表面CD94/NKG2A的表达增加。然而,CD14缺失的G-PBMC并不增加CD94/NKG2A的表达。将纯化的CD14+细胞加入CD14缺失的G-PBMC中,以剂量依赖的方式诱导CD94/NKG2A的表达,然而,这种促进CD94/NKG2A表达的作用被反应细胞和CD14+细胞之间的膜所抑制。因此,G-PBMC中的CD14+细胞诱导CD8+T细胞表达CD94/NKG2A,进而下调同种异体反应。因此,抑制T细胞上NKR的表达在调节同种异体反应中具有重要作用。
英文摘要
Although granulocyte colony-stimulating factor (G-CSF)-mobillized peripheral blood mononuclear cells (G-PBMC) grafts contain at least ten times more T cells than standard bone marrow grafts, the incidence and severity of acute graft-versus-host disease (aGVHD) is not higher than that observed with allogeneic marrow. We have shown that the induction of constimulatory molecule CD28 responsive complex in CD4+ cells appears to be suppressed by the presence of CD14+ cells in the G-PBMCIt has recently been shown that inhibitory natural killer cell receptors (NKRs) on NK cells negatively regulate NK cell and also T cell functions through their binding to MHC class I molecules. A CD94/NKG2 heterodimer serves as a receptor for HLA-E non-classical HLA-I molecules. We showed the expression of CD94/NKG2A on T cells was higher in cGVHD patients with good response to conventional immunosuppressive therapy than in cGVHD patients with poor response. Also, we reported the increased expression of CD94/NKG2A on CD8+ T cells in G-PBMC after mixed lymphocyte culture (MLC). However, CD94/NKG2A expression did not increase when CD14-depleted G-PBMC was used. The addition of purified CD14+ cells to CD14-depleted G-PBMC induced CD94/NKG2A expression in a dose-dependent fashion, however, this enhancing effect of purified CD14+ cells on CD94/NKG2A expression was inhibited by the presence of a membrane between responder cells and CD14+ cells. Therefor, CD14+ cells in G-PBMC induce CD94/NKG2A expression on CD8+ T cells, which in turn appear to down-regulate alloresponses. Therefore, inhibitory NKR expression on T cells has an important role in the regulation of alloresponse.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Tanaka J et al.: "Sequential analysis of HLA-C-specific KIR (CD158b) expressing PBMC during chronic GVHD"Bone Marrow Transport. 26. 287-290 (2000)
Tanaka J 等人:“慢性 GVHD 期间表达 PBMC 的 HLA-C 特异性 KIR (CD158b) 的序列分析”骨髓运输。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka J. et al.: "Increased expression of HLA class I specific KIR(CD94) on PBMC after allo BMT"Acta Haematol. 105. 89-91 (2001)
Tanaka J. 等人:“异基因 BMT 后 PBMC 上 HLA I 类特异性 KIR (CD94) 的表达增加”Acta Haematol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka, J., et al.: "T cell cosignaling molecules in GLHD"Ann Hematol. (in press).
Tanaka, J. 等人:“GLHD 中的 T 细胞协同信号分子”Ann Hematol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka J et al.: "Alterations in binding activity of T cell transcription factor CD28 responsive element binding complex (CD28RC) following allogeneic BMT"Eur J Haematol. 94. 333-339 (2000)
Tanaka J 等人:“同种异体 BMT 后 T 细胞转录因子 CD28 响应元件结合复合物 (CD28RC) 的结合活性发生变化”Eur J Haematol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 22 条
    Expansion of activated NK cells from cord bloood
    • 批准号:
      22591056
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2010
    • 负责人:
      TANAKA Junji
    • 依托单位:
    Transient receptor potential A1 mediates gastric distention-induced visceral pain in rats
    • 批准号:
      21590798
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      TANAKA Junji
    • 依托单位:
    Expansion of inhibitory NK cell receptor-expressing CD8 T cells and immunoregulatory CD4 T cells
    • 批准号:
      19591093
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      TANAKA Junji
    • 依托单位:
    Visceral pain and activation of MAPK in sensory neurons after noxious gastric distension
    • 批准号:
      19590740
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      TANAKA Junji
    • 依托单位:
    国内基金
    海外基金
    联合调节Thpok和PD-1增强GVL效应持久性的作用研究
    • 批准号:
      82570268
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2025
    • 负责人:
      潘彬
    • 依托单位:
    索拉非尼通过mtDNA-cGAS-Sting信号轴调控巨噬细胞和NK细胞间的免疫互话增强GVL的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      宣丽
    • 依托单位:
    Stat3缺失的供者T细胞通过PD1/PD-L1抑制GVHD 保留GVL效应的机 制研究
    索拉非尼调控移植后骨髓微环境介导巨噬细胞和NK细胞间的免疫互话诱导GVHD与GVL分离的机制研究
    • 批准号:
      82370216
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      宣丽
    • 依托单位: